BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19969329)

  • 1. The role of actinin-4 in bladder cancer invasion.
    Koizumi T; Nakatsuji H; Fukawa T; Avirmed S; Fukumori T; Takahashi M; Kanayama H
    Urology; 2010 Feb; 75(2):357-64. PubMed ID: 19969329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of plakophilin-2 and Down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer.
    Takahashi H; Nakatsuji H; Takahashi M; Avirmed S; Fukawa T; Takemura M; Fukumori T; Kanayama H
    Urology; 2012 Jan; 79(1):240.e1-8. PubMed ID: 22119253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma.
    Yamada S; Yanamoto S; Yoshida H; Yoshitomi I; Kawasaki G; Mizuno A; Nemoto TK
    Int J Oral Maxillofac Surg; 2010 Jan; 39(1):61-7. PubMed ID: 19913389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder cancer cell invasion is enhanced by cross-talk with fibroblasts through hepatocyte growth factor.
    Wang P; Nishitani MA; Tanimoto S; Kishimoto T; Fukumori T; Takahashi M; Kanayama HO
    Urology; 2007 Apr; 69(4):780-4. PubMed ID: 17445681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vascular endothelial growth factor and its receptor inhibitor on proliferation and invasion in bladder cancer.
    Nakanishi R; Oka N; Nakatsuji H; Koizumi T; Sakaki M; Takahashi M; Fukumori T; Kanayama HO
    Urol Int; 2009; 83(1):98-106. PubMed ID: 19641368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro.
    Zhang N; Sanders AJ; Ye L; Kynaston HG; Jiang WG
    Anticancer Res; 2010 Jan; 30(1):87-95. PubMed ID: 20150621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
    Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
    Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion.
    Ding Y; Wang G; Ling MT; Wong YC; Li X; Na Y; Zhang X; Chua CW; Wang X; Xin D
    Int J Oncol; 2006 Apr; 28(4):847-54. PubMed ID: 16525633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
    Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
    Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin-11 decreases the invasiveness of bladder cancer cells.
    Awsare NS; Martin TA; Haynes MD; Matthews PN; Jiang WG
    Oncol Rep; 2011 Jun; 25(6):1503-9. PubMed ID: 21468549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells.
    Kawakami S; Kageyama Y; Fujii Y; Kihara K; Oshima H
    Anticancer Res; 2001; 21(1A):213-9. PubMed ID: 11299737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells.
    Chang CC; Shieh GS; Wu P; Lin CC; Shiau AL; Wu CL
    Cancer Res; 2008 Aug; 68(15):6281-91. PubMed ID: 18676852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
    Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
    Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.
    Maas S; Warskulat U; Steinhoff C; Mueller W; Grimm MO; Schulz WA; Seifert HH
    Urology; 2004 Feb; 63(2):392-7. PubMed ID: 14972509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion.
    Davies G; Jiang WG; Mason MD
    Anticancer Res; 1999; 19(1A):547-52. PubMed ID: 10226596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.
    Du P; Ye L; Ruge F; Yang Y; Jiang WG
    Anticancer Res; 2011 Oct; 31(10):3205-12. PubMed ID: 21965727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer.
    O'Brien T; Cranston D; Fuggle S; Bicknell R; Harris AL
    Cancer Res; 1997 Jan; 57(1):136-40. PubMed ID: 8988054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.
    Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY
    Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.